Rose, Jed E. http://orcid.org/0000-0002-4861-7750
Behm, Frederique M.
Botts, Tanaia L.
Botts, David R.
Willette, Perry N.
Vocci, Frank
McCarty, John
Funding for this research was provided by:
National Institute on Drug Abuse (1R41DA033710-01A1)
BRST Labs
Article History
Received: 14 March 2022
Accepted: 26 May 2022
First Online: 30 June 2022
Declarations
:
: JER and FMB disclose research support from Foundation for a Smoke-Free World, Philip Morris International, Altria, Embera Neurotherapeutics, Inc., Otsuka Pharmaceutical, JUUL Labs, consulting with Revive pharmaceuticals, and consulting and patent purchase agreement with Philip Morris International.JM is Nicotine BRST’s Chief Scientific Officer at which he holds an equity interest.FV has consulted with Revive Therapeutics.TLB, DRB, and PNW disclose research support from Foundation for a Smoke-Free World, Philip Morris International, Altria, Embera Neurotherapeutics, Inc., Otsuka Pharmaceutical, and JUUL Labs.